Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SMCI - >>> Meet the New Stock-Split Stock That Outperformed Nvidia in the First Half and Wall Street Thinks Could Almost Double
by Adria Cimino
Motley Fool
Sep 20, 2024
https://finance.yahoo.com/news/meet-stock-split-stock-outperformed-084000909.html
Nvidia has been a tough act to follow in recent years. The artificial intelligence (AI) chip giant has delivered triple-digit increases in earnings quarter after quarter, and the share price has followed. Nvidia stock has soared more than 2,400% over the past five years, and considering the company's focus on innovation, this stellar performance may continue.
Though Nvidia has garnered the greatest share of investor attention in recent times, another tech player actually outperformed this AI powerhouse in the first half of the year. And this company followed in Nvidia's footsteps recently by announcing a stock split, a move to bring a high-flying share price down to earth -- and make the stock more accessible for a broader range of investors.
Now, Wall Street predicts this player's gains may be far from over. Let's meet the new stock-split stock that analysts think could nearly double within the coming 12 months...
.
A triple-digit first-half gain
And this stock is Super Micro Computer (NASDAQ: SMCI), a company that saw its stock price soar 188% in the first half, surpassing Nvidia's 149% increase. Though individual forecasts vary, the average Wall Street estimate calls for the stock to climb 90% from today's level.
It's important to note that this once high-flying stock has been wading through difficult waters in recent weeks. A short report released by Hindenburg Research, alleging troubles at the company, has weighed on the shares. In an unrelated move, Supermicro delayed the filing of its 10-K annual report, and this has represented an additional headwind.
I see these as short-term pressures, but they don't change Supermicro's long-term story. And considering the 20% decline in the stock since the short report, it looks dirt cheap right now -- it trades for only 13 times forward earnings estimates, down from more than 45 times earlier in the year.
In recent days, some analysts have highlighted the potential of Supermicro. For example, Needham rated Supermicro a buy in new coverage of the stock -- and Needham expects a gain of 37% in the months to come.
Why should we be so optimistic about Supermicro? First, the company has proven its ability to dominate in the area of full rack scale solutions for data centers. Supermicro's servers and other products share many common parts so the company can more quickly build a particular item to suit a customer's needs. The equipment maker also works very closely with all of the top chipmakers -- including Nvidia -- so that it can immediately include their innovations in its products. This has helped revenue in one single quarter surpass annual revenue as recently as 2021.
Supermicro's big opportunity
Second, Supermicro now faces a major opportunity that could launch a whole new wave of lasting growth for the company. One of the biggest problems facing the data centers of today and tomorrow is the fact that AI workloads produce excessive heat. Supermicro's direct liquid cooling (DLC) technology, once a slow-growth business, now promises to offer explosive growth.
The company predicts that within the coming 12 months, 25% to 30% of data centers will be equipped with DLC, and Supermicro will dominate this market. At the same time, Supermicro is preparing for demand for DLC and its equipment in general as it brings online its Malaysia facility -- one that will focus on volume and speed.
Considering forecasts of an AI market to reach $1 trillion by the end of the decade, and the key role of data centers in all of this, Supermicro's revenue could continue to climb for quite some time.
As for the stock split, Supermicro will trade at its new split-adjusted price as of Oct. 1. This won't change anything fundamental about the company or stock -- valuation and market value remain the same. So, it won't act as a catalyst for share performance, but it is a positive move as it will make it easier for more investors to buy the stock over time.
All of this represents a lot of positive points for Supermicro, setting the stage for major growth potential -- and making it a fantastic stock to buy on the dip.
<<<
---
AbbVie -- >>> AbbVie raised its dividend payout by a stunning 270% over the past 10 years but isn't trading like a stock that rapidly raises its quarterly payout. At recent prices, it offers a 3.2% yield.
https://www.fool.com/investing/2024/09/19/2-unstoppable-sp-500-stocks-that-keep-beating-the/
Shares of AbbVie have been under pressure because its former lead drug Humira lost patent-protected market exclusivity in the U.S. in 2023. In the first half of 2024, Humira sales decreased 33% year over year to $5.1 billion.
Declining Humira sales are a challenge, but AbbVie has done a pretty good job reinvesting the profits it produced. In 2019, the company launched Skyrizi for psoriasis and Rinvoq for arthritis, and these two drugs are offsetting Humira losses on their own.
Combined sales of the pair reached $7.3 billion in the first half of 2024 and are a long way from being finished. In February, management told investors it expects Rinvoq and Skyrizi to generate more than $27 billion in combined annual sales by 2027.
Investors will be glad to learn that Rinvoq and Skyrizi aren't the only blockbuster drugs that AbbVie's launched in recent years. For example, its oral treatments for migraine headaches, Ubrelvy and Qulipta, are expected to produce more than $3 billion in combined annual sales at their peaks.
AbbVie shares have been trading for around 17.9x the midpoint of management's earnings expectations for 2024. That's a historically high multiple for this company, but pressure from Humira's competition is already beginning to subside. With plenty of growth drivers to push earnings higher, investors who buy at recent prices have a great chance to come out miles ahead over the long run.
<<<
---
>>> Intuitive Machines Shares Soar on NASA Pact for Near-Space Grid
Bloomberg
by Carmen Reinicke
September 18, 2024
https://finance.yahoo.com/news/intuitive-machines-shares-soar-nasa-154730433.html
(Bloomberg) -- Intuitive Machines Inc. shares are surging after the space exploration firm said it won another NASA contract. This one could be worth as much as $4.8 billion.
The stock of the the first private company to land a spacecraft intact on the moon soared as much as 66% Wednesday, the biggest intraday jump in 18 months. The price of Intuitive Machines’ shares have more than tripled since the start of the year after the Houston-based firm was awarded a series of NASA accords.
The latest contract is for communication and navigation services for missions in the near-space region, from the Earth’s surface to beyond the Moon. In August, the company won a NASA contract to deliver science and technology payloads, and was one of three companies to receive a contract to develop vehicles that astronauts may drive on the lunar surface in April.
The recent win is “a significant catalyst and validation towards LUNR’s outlook and the company’s ability to continue to win contracts,” Cantor Fitzgerald analyst Andres Sheppard wrote in a note dated Tuesday, referring to the company by its ticker symbol.
“More importantly, LUNR was the only awardee of this contract,” Sheppard added, noting the expectation was that the contract would be awarded to multiple companies.
The first set of task orders for the contract will be about $150 million — the deal has a base period of five years with an added five-year option period for a total maximum potential value of $4.8 billion. As part of the contract, Intuitive Machines will introduce lunar satellite data and transmission services — which the company sees as a key for its goal to commercialize lunar activities.
The near space network pact “provides significant backlog and long-term financial stability, something many space peers lack,” Josh Sullivan, an analyst at Benchmark wrote Wednesday. Intuitive Machines’ “path to becoming the preeminent lunar infrastructure player took a big step forward.”
Intuitive Machines stock has been whipsawed this year and — despite the recent surge — remains more than 20% below a February peak following its moon landing.
Wall Street is overwhelmingly bullish on shares of Intuitive Machines with all five analysts tracked by Bloomberg rating the company the equivalent of a buy. The average 12-month price target of $9.80 implies more the stock could climb roughly another 18% from where shares currently trade.
“This contract marks an inflection point in Intuitive Machines’ leadership in space communications and navigation,” Intuitive Machines CEO Steve Altemus said in a statement Tuesday.
<<<
---
Cintas - >>> One of Wall Street's Highest-Flying Stocks -- a Nearly 125,000%-Gainer Since Its IPO -- Has Officially Completed Its Latest Stock Split
Motley Fool
by Sean Williams
September 13, 2024
https://finance.yahoo.com/news/one-wall-streets-highest-flying-085100349.html
While it's perfectly normal for a hot trend to be captivating the attention of Wall Street and investors, two buzzy trends at the same time are somewhat rare. In addition to investors piling into stocks associated with the artificial intelligence (AI) revolution, they seemingly can't get enough of companies announcing stock splits.
A stock split is a tool on the proverbial utility belt for publicly traded companies that allows them to adjust their share price and outstanding share count by the same magnitude. Despite these nominal changes, stock splits are purely cosmetic and have no impact on a company's market cap or its operating performance.
Although stock splits can occur in both directions — reverse-stock splits increase a company's share price, while forward-stock splits reduce it — a majority of investors favor companies completing forward splits. Businesses undertaking forward splits are usually outperforming their peers in every respect, which is what propels their underlying stock higher.
In 2024, 13 leading companies have announced or completed a stock split, all but one of which is a forward-stock split. Today just happens to be the day one of these phenomenal businesses will be trading at its post-split price for the first time.
This nearly 125,000%-gainer just completed its sixth split since going public
Earlier this week, satellite-radio operator Sirius XM Holdings enjoyed its time in the sun as the only prominent reverse-stock split of 2024. But today, Sept. 12, it's all about recognizing corporate identity uniform and business services provider Cintas (NASDAQ: CTAS).
Back on May 2, the company's board announced plans to complete a 4-for-1 split following the close of trading on Sept. 11. With the company's shares closing at north of $816 on Sept. 10, the largest split in the company's history will reduce its share price to a shade over $200.
Since its initial public offering (IPO) in 1983, Cintas has delivered a total return (i.e., factoring in dividend payments along with the cumulative return of its shares) of almost 125,000% and completed a half-dozen stock splits:
April 1987: 2-for-1 forward split
April 1991: 3-for-2
April 1992: 2-for-1
November 1997: 2-for-1
March 2000: 3-for-2
September 2024: 4-for-1
The catalyst fueling this growth is, first and foremost, the growth of the U.S. economy. Although recessions are a perfectly normal and inevitable aspect of the economic cycle, history tells us that these downturns tend to be short-lived. Only three of 12 U.S. recessions since the end of World War II have lasted at least 12 months.
On the other hand, most periods of growth endure for multiple years. An expanding economy tends to lead to higher demand for corporate uniforms and the various products and services Cintas provides, such as towels, floor mats, and safety kits.
Beyond macroeconomic catalysts, Cintas has also benefited from a steady diet of bolt-on acquisitions. Purchasing Zee Medical and G&K Services are perfect examples of Cintas expanding its product and service ecosystem, dangling a carrot for new clients, and providing itself the opportunity to cross-sell more of its products to existing clients.
Innovation is another key puzzle piece for Cintas. Ongoing product development for its line of rental uniforms, as well as its various business product lines, tends to keep customers loyal.
Last but not least, Cintas has more than 1 million corporate clients. This level of diversification all but ensures that no one single business is paramount to its success or capable of sinking the proverbial ship.
Despite Cintas's long-term success, additional near-term upside could be a tough ask
While Cintas has a pretty clear path to long-term growth, thanks largely to being tied at the hip to the U.S. economy, additional upside for shares of the company over the next couple of years could be a tough ask.
For one, there are mounting concerns that a U.S. recession is brewing. A couple of data points and predictive metrics, including the first notable decline in U.S. M2 money supply since the Great Depression, as well as the longest yield-curve inversion in history, suggest coming weakness for the economy and stock market.
Though stocks don't move in-tandem with the U.S. economy, Cintas is undeniably cyclical. Most of its clients are liable to feel some degree of pain if economic growth slows or contracts, which would, in turn, be expected to slow down its own growth rate.
To build on this point, both the broader market and Cintas are historically expensive.
According to the S&P 500's Shiller price-to-earnings (P/E) ratio, which is also commonly referred to as the cyclically adjusted price-to-earnings ratio (CAPE ratio), the stock market has only been as pricey as it is now two other times, when back-tested to January 1871.
On Sept. 10, the S&P 500's Shiller P/E, which is based on average inflation-adjusted earnings from the prior 10 years, closed at 35.33, or more than double than 153-year average of 17.16. More importantly, previous instances where the S&P 500's Shiller P/E topped 30 during a bull market rally were, eventually (key word!), followed by declines of at least 20%.
Cintas ended Sept. 10 at roughly 54 times its trailing-12-month (TTM) earnings per share (EPS) and a nosebleed 44 times forward-year EPS. You'd have to go back to the late 20th century to find the last time Cintas was valued at 54 times TTM EPS.
While a forecast sales growth rate of 7% in the current and upcoming year is admirable for a company of its size, it doesn't come to close to justifying a forward P/E ratio of 44.
This is a rare instance of a rock-solid business whose stock simply isn't worth buying at the moment.
<<<
---
>>> Arcosa, Inc. (ACA) -- Share Price Upside: 16%
Number of Hedge Fund Investors In Q2 2024: 25
Average Analyst Share Price Target: $105.8
https://finance.yahoo.com/news/arcosa-inc-aca-one-oppenheimer-232721199.html
Arcosa, Inc. (NYSE:ACA) is a mid sized engineering and construction firm based in Dallas, Texas. It is a diversified construction materials and products company that sells items such as aggregates, tower structures, and steel components for vehicles.
Arcosa, Inc. (NYSE:ACA)'s business, which is geared solely towards construction products makes the firm sensitive to high interest rates as they depress construction activity and real estate performance. Consequently, the fact that its shares have risen 22% over the past twelve months is unsurprising. Equally unsurprising is the fact that Arcosa's stock soared by 4.6% the day Fed Chairman Jerome Powell confirmed that interest rate cuts would start soon. This suggests pent up momentum for the stock, and Arcosa, Inc. (NYSE:ACA) could benefit if construction activity picks up.
Additionally, since it is an American company, the firm could also see tailwinds from government spending through the Bipartisan Infrastructure Act. Oppenheimer believes that Arcosa, Inc. has "well-established positions in attractive markets with favorable long-term demand drivers, which should provide it with compelling organic and acquisition opportunities."
Arcosa's management touted the benefits of a recent acquisition during the Q2 2024 earnings call:
"It’s a very, very stable market. When you look at the financials over a long period of time, are very stable, with high margins, a very good market. This company has done a great job expanding over the last several years. And there are opportunities to consolidate not only in the main market of the New York, New Jersey area, but they also have other quarries around it. So there are opportunities. One thing that’s very interesting when you look at the competitors in the region, you have many of the big guys around it, which is something we like. We like to compete against some of the larger peers. But there are also some smaller bolt-on opportunities for the future. As I said before, our priority right now is deleveraging, and that’s going to be our focus.
And there are opportunities to grow organically, and implement some other actions to improve efficiency, et cetera. But also to learn from this company. This company has done a fantastic job and there are things we can bring to them, but there are also things we can learn from them. So very excited about it."
Overall ACA ranks 16th on our list of Oppenheimer's favorite stocks for the next 12 months.
<<<
---
>>> Why Fabrinet Stock Blasted Nearly 16% Higher Today
by Eric Volkman
Motley Fool
Aug 20, 2024
https://finance.yahoo.com/news/why-fabrinet-stock-blasted-nearly-210009685.html
Optics equipment supplier Fabrinet (NYSE: FN) was quite the double-digit outperformer on the second trading day of the week. Tuesday saw the company's share price skyrocket by nearly 16%, thanks to an earnings report that well outpaced expectations. Fabrinet stock's performance on the day was particularly impressive considering that the S&P 500 index ended in negative territory, closing the day down by 0.2%.
A good way to ring in the new fiscal year
Fabrinet closed out its fiscal 2024 in style, delivering fourth-quarter results that easily topped the average analyst estimates. For the period ended June 28, it took in more than $753 million in revenue, a figure that was 15% higher year over year. Non-GAAP (adjusted) net income leaped even higher, rising by 29% to hit $88 million, or $2.41 per share.
On average, analysts tracking the stock were expecting a notably more modest performance. Collectively, they were modeling less than $733 million on the top line, and only $2.24 per share for adjusted net profit.
In its earnings release, Fabrinet did not fail to mention that the quarter was the fourth frame in a row in which it notched record revenue and earnings-per-share figures.
Fabrinet also said that its board of directors has approved an expansion of the company's existing stock buyback program. The new authorization is for $139.5 million worth of its ordinary shares, which brings the total authorized amount to $434.3 million. Of this figure, $200 million is remaining for repurchases.
Crushing it on guidance, too
Fabrinet also proffered guidance for its current (first) quarter. The company is forecasting that it will earn $760 million to $780 million in revenue, with adjusted net income coming in at $2.33 to $2.40 per share. As with the fourth-quarter results these ranges topped the consensus analyst estimates, which called for nearly $752 million on the top line, and $2.25 for adjusted per-share profitability.
<<<
---
>>> Mastercard (MA) is a payment processing company with a total of around 3.4 billion debit and credit cards issued worldwide. The business is one of two dominant payment companies in the world with the other being Visa, and had a market share of 27.4% in the U.S. back in 2022, up from its five-year average of 22%, according to Nilson Report.
https://finance.yahoo.com/news/3-magnificent-stocks-im-never-091000164.html
Mastercard boasts solid financials with revenue rising from $18.9 billion in 2021 to $25.1 billion in 2023. Net income jumped from $8.7 billion to $11.2 billion over the same period, and the business is also highly free-cash-flow generative with an average of $9.9 billion churned out over the three years. Mastercard also increased its quarterly dividend by 16% year over year to $0.66 at the end of last year, representing more than a decade of consecutive dividend increases.
The strong performance has continued in the first half of 2024. Mastercard saw its revenue rise 10% year over year to $13.3 billion while net income shot up 20.4% year over year to $6.3 billion. The good results were attributed to robust consumer spending and a tourism rebound that saw cross-border transaction volume climb 17% year over year for the second quarter of 2024. Free cash flow came in at $4.1 billion, inching up 2.6% year over year from $4 billion in the previous comparative period.
With Mastercard's solid reputation and track record, I am confident that the business can continue to grow steadily over the years while increasing its dividends along the way.
<<<
---
>>> Winmark: Powering the circular economy megatrend
https://finance.yahoo.com/news/2-dividend-stocks-double-now-143800565.html
Home to over 1,300 resale franchises across its Plato's Closet, Play It Again Sports, Once Upon A Child, Music Go Round, and Style Encore brands, Winmark is a shining example of the effect that circular economies can have on the world. Thanks to its operations, the company estimates that since 2010, it has put over 1.7 billion items back to good use, helping them avoid landfills, storage units, garages, or the top shelves of closets.
While this feel-good purpose alone makes Winmark an exciting stock, the company's long-term partnerships with its franchisees could prove to be the true magic.
Since it's thinking decades ahead (sometimes even multiple generations ahead), Winmark isn't overly concerned with what happens quarter to quarter. What it wants to do is build a lasting legacy alongside its franchisees. Speaking to Jim Gilles with The Motley Fool, Chief Executive Officer Brett Heffes expounded upon this notion:
Because what happens, is our most successful franchisees, they understand that their business is a legacy asset in the community. They manage the business for themselves, the community, but more importantly, the next generation. This legacy mindset leads to continued investment on our part, whether it's technology, whether it's marketing, whether it's operations, and it just allows us to fulfill our mission.
In operating over this generational time frame, Winmark takes a slow and steady approach to its growth, inching sales higher by 4% annually over the last decade. By taking its time to vet new franchisees and scout new potential store locations, the company has generated a ridiculous 188% ROIC and a free cash flow margin of 51%.
Armed with this cash generation, Winmark always looks to reward shareholders, as it typically pays out almost all excess cash to shareholders in the form of special dividends in many years. However, if Heffes deems the company's shares to be trading below intrinsic value, he'll also swoop in to repurchase shares, which led to a 4% annualized decline in share count since 2014.
With Statista projecting the circular economy to nearly double its sales between 2022 and 2026, Winmark is well-positioned to continue rewarding investors for decades -- if not generations -- to come.
<<<
---
Nvidia - >>> Exclusive: Behind the plot to break Nvidia’s grip on AI by targeting software
Reuters
by Max A. Cherney
3-25-24
https://finance.yahoo.com/news/exclusive-behind-plot-break-nvidia-110359868.html
SAN FRANCISCO (Reuters) - Nvidia earned its $2.2 trillion market cap by producing artificial-intelligence chips that have become the lifeblood powering the new era of generative AI developers from startups to Microsoft, OpenAI and Google parent Alphabet.
Almost as important to its hardware is the company’s nearly 20 years' worth of computer code, which helps make competition with the company nearly impossible. More than 4 million global developers rely on Nvidia's CUDA software platform to build AI and other apps.
Now a coalition of tech companies that includes Qualcomm, Google and Intel plans to loosen Nvidia’s chokehold by going after the chip giant’s secret weapon: the software that keeps developers tied to Nvidia chips. They are part of an expanding group of financiers and companies hacking away at Nvidia's dominance in AI.
"We're actually showing developers how you migrate out from an Nvidia platform," Vinesh Sukumar, Qualcomm's head of AI and machine learning, said in an interview with Reuters.
Starting with a piece of technology developed by Intel called OneAPI, the UXL Foundation, a consortium of tech companies, plans to build a suite of software and tools that will be able to power multiple types of AI accelerator chips, executives involved with the group told Reuters. The open-source project aims to make computer code run on any machine, regardless of what chip and hardware powers it.
"It's about specifically - in the context of machine learning frameworks - how do we create an open ecosystem, and promote productivity and choice in hardware," Google's director and chief technologist of high-performance computing, Bill Hugo, told Reuters in an interview. Google is one of the founding members of UXL and helps determine the technical direction of the project, Hugo said.
UXL's technical steering committee is preparing to nail down technical specifications in the first half of this year. Engineers plan to refine the technical details to a "mature" state by the end of the year, executives said. These executives stressed the need to build a solid foundation to include contributions from multiple companies that can also be deployed on any chip or hardware.
Beyond the initial companies involved, UXL will court cloud-computing companies such as Amazon.com and Microsoft's Azure, as well as additional chipmakers.
Since its launch in September, UXL has already begun to receive technical contributions from third parties that include foundation members and outsiders keen on using the open-source technology, the executives involved said. Intel's OneAPI is already useable, and the second step is to create a standard programming model of computing designed for AI.
UXL plans to put its resources toward addressing the most pressing computing problems dominated by a few chipmakers, such as the latest AI apps and high-performance computing applications. Those early plans feed in to the organization's longer-term goal of winning over a critical mass of developers to its platform.
UXL eventually aims to support Nvidia hardware and code, in the long run.
When asked about the open source and venture-funded software efforts to break Nvidia’s AI dominance, Nvidia executive Ian Buck said in a statement: "The world is getting accelerated. New ideas in accelerated computing are coming from all across the ecosystem, and that will help advance AI and the scope of what accelerated computing can achieve."
NEARLY 100 STARTUPS
The UXL Foundation's plans are one of many efforts to chip away at Nvidia's hold on the software that powers AI. Venture financiers and corporate dollars have poured more than $4 billion into 93 separate efforts, according to custom data compiled by PitchBook at Reuters’ request.
The interest in unseating Nvidia through a potential weakness in software has ramped up in the last year, and startups aiming to poke holes in the company's leadership gobbled up just over $2 billion in 2023 compared with $580 million from a year ago, according to the data from PitchBook.
Success in the shadow of Nvidia's group on AI data crunching is an achievement that few of the startups will be able to achieve. Nvidia's CUDA is a compelling piece of software on paper, as it is full-featured and is consistently growing both from Nvidia's contributions and the developer community.
"But that's not what really matters," said Jay Goldberg, chief executive of D2D Advisory, a finance and strategy consulting firm. "What matters is the fact that people have been using CUDA for 15 years, they built code around it."
<<<
---
>>> UnitedHealth unit will start processing $14 billion medical claims backlog after hack
Reuters
by Leroy Leo
https://www.msn.com/en-us/money/companies/unitedhealth-unit-will-start-processing-14-billion-medical-claims-backlog-after-hack/ar-BB1kntGE?OCID=ansmsnnews11
(Reuters) - UnitedHealth Group said on Friday its Change Healthcare unit will start to process the medical claims backlog of more than $14 billion as it resumes some software services disrupted by a cyberattack last month.
The company has been scrambling to resume services at the technology unit that was hit by a cyberattack on Feb. 21, disrupting payments to U.S. doctors and healthcare facilities and forcing the U.S. government to launch a probe.
Community health centers that serve more than 30 million poor and uninsured patients have been especially hit.
The company has advanced payments of more than $2.5 billion so far to provide assistance to healthcare providers financially affected by the disruption, an increase from the over $2 billion it had disclosed on Monday. UnitedHealth also extended the repayment period for providers, who will now have 45 business days to return the relief funds.
Change Healthcare is a key player in the U.S. healthcare system that depends heavily on insurance, processing about 50% of medical claims for around 900,000 physicians, 33,000 pharmacies, 5,500 hospitals and 600 laboratories.
The unit was breached by a hacking group called ALPHV, also known as "BlackCat", creating a knock-on effect that the largest U.S. health insurer is expected to take several months from which to fully recover.
The health insurer said its software for preparing medical claims Assurance went online on Monday, while its largest clearinghouse Relay Exchange will resume on the weekend of March 23.
A clearinghouse acts as a middleman between a healthcare provider and a health plan that checks claims to ensure they do not contain errors before forwarding them for payment.
The insurer said it will work with payers to ensure there are a maximum number of available locations for claims and is actively coordinating with other clearinghouses to make sure there are no capacity issues.
UnitedHealth had suspended paperwork required to get approval for insurance coverage for most outpatient services, as well as review of inpatient admissions for government-backed Medicare Advantage plans to help those impacted.
UnitedHealth also expects to engage all those who submitted claims during the week of March 25.
The company's other products that handle eligibility of claims such as Clearance and Coverage Insight as well as pharmacy claims submission software MedRx and Reimbursement Manager are expected to go online next week.
Several more products are likely to go online over the weeks of April 1 and April 8, the company said.
Some products, however, were not listed in Friday's update as it does not yet have clarity of when they will be restored, the company said, adding it will provide updated information as those timelines become clear.
<<<
---
Resmed - >>> Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
GlobeNewswire
ResMed Inc.
March 6, 2024
https://finance.yahoo.com/news/introducing-airfit-f40-experience-unprecedented-140500242.html
Enhances sleep apnea therapy by combining the ease and comfort of an ultra-compact, under-the-nose full-face design with the effectiveness of a traditional over-the-nose full-face mask.
Featuring the AdaptiSeal™ cushion made of 100% soft silicone to adapt to various facial contours, allowing for a secure and comfortable seal throughout the night.
96% of patients using the AirFit F40 said they have the freedom to sleep in their preferred position and change positions through the night.1
SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), a global leader in digital health and cloud-connected medical devices that transform care for people with sleep apnea and other chronic respiratory diseases, today announced the U.S. launch of the AirFit F40, an ultra-compact, full-face mask offering the comfort of smaller masks without sacrificing performance in order to help improve sleep apnea therapy compliance.2
Finding the right mask with the right fit and comfort can be daunting, especially for individuals requiring high-pressure CPAP treatment. The AirFit F40 addresses this problem by providing the necessary pressure support in a more comfortable, lower-profile full-face mask. The mask is ideal for people who sleep on their side, are claustrophobic, and want the stability and seal of a universal fit mask in a minimalist design. In a ResMed clinical study, 88% of patients rated AirFit F40's mask cushion as soft and comfortable and 100% found AirFit F40 easy to use.3
"Most users prefer smaller and more streamlined masks, but traditional under-the-nose full-face masks can be challenging to fit properly, maintain a seal, and handle higher pressures. Our new AirFit F40 addresses this problem by offering the best of both worlds: an ultra-compact full-face mask with the high seal performance of an over-the-nose mask – bridging the gap between compactness and effectiveness in full-face masks,” said Justin Leong, ResMed chief product officer.
A key feature of the AirFit F40 is the AdaptiSeal™ cushion, a 100% soft silicone cushion designed to maintain a facial seal, even when moving around during sleep. Additional features include:
A fully flexible frame that keeps the assembly away from patients’ eyes and ears.
A full-face mask with a quick-release short tube, reducing tube drag and offering a convenient way to detach and reattach the mask to the device during the night.
Headgear without top strap adjustment, which makes for an easier setup and adjustment process.
A new textile material and a dark grey color, offering a more modern look.
AirFit F40 is the latest in ResMed’s family of innovative CPAP masks, connected devices, and digital health technologies for helping millions with sleep apnea, COPD, and other chronic diseases sleep, breathe, and live better.
AirFit F40 masks are available in the U.S., with plans to launch in Canada, followed by EMEA, Latin America, and APAC. For more information, visit ResMed.com/AirFitF40.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we help improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.
<<<
---